TAKEDA PHARMACEUTICAL CO LTD's ticker is and the CUSIP is 874060905. A total of 4 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,006 | +1281.4% | 259,000 | +1300.0% | 0.00% | – |
| Q2 2023 | $290 | -29.6% | 18,500 | -26.0% | 0.00% | – |
| Q1 2023 | $412 | -89.5% | 25,000 | -90.0% | 0.00% | -100.0% |
| Q4 2022 | $3,912 | -99.9% | 250,800 | +11.0% | 0.00% | +33.3% |
| Q3 2022 | $2,931,000 | -4.3% | 226,000 | +3.6% | 0.00% | 0.0% |
| Q2 2022 | $3,062,000 | +1.9% | 218,100 | +4.0% | 0.00% | 0.0% |
| Q1 2022 | $3,004,000 | +804.8% | 209,800 | +759.8% | 0.00% | – |
| Q4 2021 | $332,000 | -15.5% | 24,400 | +4.7% | 0.00% | – |
| Q3 2021 | $393,000 | 0.0% | 23,300 | -0.4% | 0.00% | – |
| Q2 2021 | $393,000 | -68.7% | 23,400 | +3301.2% | 0.00% | -100.0% |
| Q1 2021 | $1,256,000 | +1.9% | 688 | +1.5% | 0.00% | 0.0% |
| Q4 2020 | $1,233,000 | +29.8% | 678 | +27.2% | 0.00% | +100.0% |
| Q3 2020 | $950,000 | +26.7% | 533 | +27.2% | 0.00% | 0.0% |
| Q2 2020 | $750,000 | -3.0% | 419 | -17.8% | 0.00% | 0.0% |
| Q1 2020 | $773,000 | – | 510 | +16.4% | 0.00% | – |
| Q4 2019 | $0 | – | 438 | +1.4% | 0.00% | – |
| Q3 2019 | $0 | – | 432 | -7.9% | 0.00% | – |
| Q2 2019 | $0 | – | 469 | -26.3% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 636 | +4792.3% | 0.00% | – |
| Q4 2018 | $21,000 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 58,400 | $1,034,000 | 0.01% |
| JPMORGAN CHASE & CO | 427,550 | $7,512,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 469 | $0 | 0.00% |